Vivus Inc (VVUS.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|66||2013||Independent Chairman of the Board|
|63||2017||Interim Chief Executive Officer, Director|
|48||2015||Chief Financial Officer, Chief Accounting Officer|
|50||2014||Senior Vice President - Business Development, General Counsel, Secretary|
|47||2016||Chief Medical Officer|
- BRIEF-Vivus Announces Change In Leadership
- BRIEF-Vivus reports third quarter 2017 financial results
- BRIEF-VIVUS and Alvogen announce marketing agreement for Qsymia in the Republic of Korea
- BRIEF-Dr.Reddy's Labs says overall impact on financials of settlement disputes with Vivus not likely to be material
- BRIEF-Vivus reports settlement with Dr. Reddy's laboratories on qsymia patent litigation